n-acylidrazone derivatives for selective t-cell inhibitor and drug for antilymphoid neoplasia.

• 收藏
• 分享

专利权人:

CHONG KUN DANG PHARMACEUTICAL CORP;INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

发明人:

CHANGGON LEE,HOJIN CHOI,JAEWON LEE,NINA HA,SONG-MIN LEE,SU KIL SEO,SUNMI LEE

申请号：

BR112015004432

公开号：

BR112015004432A2

申请日:

2013.08.29

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention relates to novel N-acylhydrazone derivatives, and more particularly to novel N-acylhydrazone derivatives having selective T cell inhibitory activity and/or anti-lymphoid malignancy activity, stereoisomers thereof, pharmaceutically acceptable salts thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing the same, treatment methods using the compositions, and methods for preparing the novel N-acylhydrazone derivatives.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/